Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily

Akero Therapeutics (AKRO) Technical Analysis

456 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Akero Therapeutics Inc’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is 0.37, suggesting Akero Therapeutics Inc is a Sell.
Akero Therapeutics Inc’s (AKRO) 20-Day exponential moving average is 26.50, while Akero Therapeutics Inc’s (AKRO) share price is $28, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 50-Day exponential moving average is 25.74, while Akero Therapeutics Inc’s (AKRO) share price is $28, making it a Buy.

Akero Therapeutics (AKRO) Pivot Points

Sep 20, 2024, 02:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.66
25.46
26.21
27.01
27.76
28.56
29.31
Fibonacci
25.46
26.05
26.42
27.01
27.60
27.97
28.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Sep 20, 2024, 02:40 AM
Period
Simple
Exponential
MA5
27.14Buy
27.12Buy
MA10
26.55Buy
26.80Buy
MA20
26.60Buy
26.50Buy
MA50
26.24Buy
25.74Buy
MA100
23.80Buy
24.79Buy
MA200
23.45Buy
23.96Buy
Akero Therapeutics Inc’s (AKRO) 10-Day exponential moving average is 26.80, while Akero Therapeutics Inc’s (AKRO) share price is $28, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 100-Day exponential moving average is 24.79, while Akero Therapeutics Inc’s (AKRO) share price is $28, making it a Buy.
Akero Therapeutics Inc’s (AKRO) stock price is $28 and Akero Therapeutics Inc’s (AKRO) 50-day simple moving average is 26.24, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $28 and Akero Therapeutics Inc’s (AKRO) 100-day simple moving average is 23.80, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $28 and Akero Therapeutics Inc’s (AKRO) 200-day simple moving average is 23.45, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Sep 20, 2024, 02:40 AM
Name
Value
Implied Action
RSI (14)
61.72
Neutral
STOCH (9,6)
70.21
Neutral
STOCHRSI (14)
62.99
Neutral
MACD (12,26)
0.37
Sell
ADX (14)
25.83
Neutral
Williams %R
-19.84
Sell
CCI (14)
185.68
Sell
ATR (14)
1.33
-
Ultimate Oscillator
52.34
Neutral
ROC
4.13
Buy
Akero Therapeutics Inc’s (AKRO) Relative Strength Index (RSI) is 61.72, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Trend Strength Indicator (ADX) is 25.83, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Commodity Channel Index (CCI) is 185.68, creating a Sell signal.
Akero Therapeutics Inc’s (AKRO) Price Rate of Change (ROC) is 4.13, creating a Buy signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Buy.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 61.72, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is 0.37, which suggests AKRO is a Sell.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 27.14, which suggests AKRO is a Buy.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 26.60, which suggests AKRO is a Buy.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 26.24, which suggests AKRO is a Buy.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 23.45, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -19.84, which suggests AKRO is a Sell.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is 185.68, which suggests AKRO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis